Fuqua SAW - Search Results

1

Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets.

Gates LA, Gu G, Chen Y, Rohira AD, Lei JT, Hamilton RA, Yu Y, Lonard DM, Wang J, Wang SP, Edwards DG, Lavere PF, Shao J, Yi P, Jain A, Jung SY, Malovannaya A, Li S, Shao J, Roeder RG, Ellis MJ, Qin J, Fuqua SAW, O'Malley BW, Foulds CE. Gates LA, et al. Among authors: fuqua saw. Oncogene. 2018 Aug;37(33):4581-4598. doi: 10.1038/s41388-018-0284-2. Epub 2018 May 11. Oncogene. 2018. PMID: 29748621 Free PMC article.

2

Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors.

Fuqua SA, Fitzgerald SD, Allred DC, Elledge RM, Nawaz Z, McDonnell DP, O'Malley BW, Greene GL, McGuire WL. Fuqua SA, et al. Cancer Res. 1992 Jan 15;52(2):483-6. Cancer Res. 1992. PMID: 1728420

3

Variant human breast tumor estrogen receptor with constitutive transcriptional activity.

Fuqua SA, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW, McGuire WL. Fuqua SA, et al. Cancer Res. 1991 Jan 1;51(1):105-9. Cancer Res. 1991. PMID: 1988075

4

p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer.

Elledge RM, Clark GM, Fuqua SA, Yu YY, Allred DC. Elledge RM, et al. Cancer Res. 1994 Jul 15;54(14):3752-7. Cancer Res. 1994. PMID: 8033095

5

The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain.

Fuqua SA, Allred DC, Elledge RM, Krieg SL, Benedix MG, Nawaz Z, O'Malley BW, Greene GL, McGuire WL. Fuqua SA, et al. Breast Cancer Res Treat. 1993;26(2):191-202. doi: 10.1007/BF00689692. Breast Cancer Res Treat. 1993. PMID: 8219256

6

Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.

Herynk MH, Lewis MT, Hopp TA, Medina D, Corona-Rodriguez A, Cui Y, Beyer AR, Fuqua SA. Herynk MH, et al. Oncogene. 2009 Sep 10;28(36):3177-87. doi: 10.1038/onc.2009.174. Epub 2009 Jun 29. Oncogene. 2009. PMID: 19561644 Free PMC article.

7

A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactions.

Herynk MH, Hopp T, Cui Y, Niu A, Corona-Rodriguez A, Fuqua SA. Herynk MH, et al. Breast Cancer Res Treat. 2010 Jul;122(2):381-93. doi: 10.1007/s10549-009-0580-1. Epub 2009 Oct 20. Breast Cancer Res Treat. 2010. PMID: 19842032 Free PMC article.

8

Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity.

Barone I, Iacopetta D, Covington KR, Cui Y, Tsimelzon A, Beyer A, Andò S, Fuqua SA. Barone I, et al. Oncogene. 2010 Apr 22;29(16):2404-14. doi: 10.1038/onc.2009.520. Epub 2010 Jan 25. Oncogene. 2010. PMID: 20101208 Free PMC article.

9

Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.

Barone I, Brusco L, Gu G, Selever J, Beyer A, Covington KR, Tsimelzon A, Wang T, Hilsenbeck SG, Chamness GC, Andò S, Fuqua SA. Barone I, et al. J Natl Cancer Inst. 2011 Apr 6;103(7):538-52. doi: 10.1093/jnci/djr058. Epub 2011 Mar 29. J Natl Cancer Inst. 2011. PMID: 21447808 Free PMC article.

10

Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression.

Giordano C, Catalano S, Panza S, Vizza D, Barone I, Bonofiglio D, Gelsomino L, Rizza P, Fuqua SA, Andò S. Giordano C, et al. Oncogene. 2011 Sep 29;30(39):4129-40. doi: 10.1038/onc.2011.124. Epub 2011 Apr 18. Oncogene. 2011. PMID: 21499302 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters